Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00955461 · ClinicalTrials.gov registry record · NA
Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System
A NA study, sponsored by ConBio, a Cynosure Company.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00955461: Completed NA study, sponsored by ConBio, a Cynosure Company.
NCT00955461 is a NA study that has completed, run by ConBio, a Cynosure Company. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00955461, a NA study, has completed, sponsored by ConBio, a Cynosure Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the results of treatment between the side of the face treated with the RevLite Laser and the side of the face treated with a fractionated laser system.
Interventions
- PROCEDURE RevLite laser treatment
- PROCEDURE Fractionated Laser treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-02 |
| Phase | NA |
What the finished NCT00955461 record still lists
NCT00955461 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which RevLite laser treatment is the first listed.
NCT00955461 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00955461 about?
NCT00955461 is a clinical study titled "Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System". The purpose of this study is to compare the results of treatment between the side of the face treated with the RevLite Laser and the side of the face treated with a fractionated laser system.
What is the current status of trial NCT00955461?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-12. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00955461?
The interventions under investigation include: RevLite laser treatment (PROCEDURE), Fractionated Laser treatment (PROCEDURE).
Who is sponsoring clinical trial NCT00955461?
This trial is sponsored by ConBio, a Cynosure Company, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00955461's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia